Retransfusion drains offer no advantage in the care of arthroplasty patients .
This report has been verified
by one or more authors of the
original publication.
Autologous Drains in Arthroplasty: A Randomized Control Trial
J Arthroplasty. 2008 Sep;23(6):808-13. Epub 2008 Feb 1380 patients of any age scheduled to undergo cemented hip or knee arthroplasty were randomized to the removal of drain at 6 or 24 hours after surgery. No difference in the hemoglobin drop, allogenic transfusion rates, length of hospital stay, complication rate or in rehabilitation process was seen between the groups. Only the wound healing appeared to be subjectively better in the 6-hour group for hip and knee replacement patients.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
